Cyclacel Pharmaceuticals, INC. (BGMSP) SEC Filings — 2024
40 SEC filings for Cyclacel Pharmaceuticals, INC. (BGMSP) in 2024.
Filings
- Cyclacel Pharmaceuticals Faces Delisting Concerns — 8-K · Dec 12, 2024
- Cyclacel Pharmaceuticals Files 8-K: Agreements & Equity Update — 8-K · Nov 15, 2024
- Cyclacel Pharmaceuticals, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Cyclacel Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Cyclacel Pharmaceuticals to be Acquired by Verastem, Inc. — 8-K · Nov 12, 2024
- Cyclacel Pharmaceuticals Reports Q3 2024 Results — 10-Q · Nov 12, 2024
- Cyclacel Pharmaceuticals Faces Nasdaq Delisting — 8-K · Oct 24, 2024
- Cyclacel Pharmaceuticals Files S-1 Registration — S-1 · Oct 9, 2024
- Verastem to Acquire Cyclacel Pharmaceuticals — 8-K · Sep 6, 2024
- Cyclacel Pharmaceuticals Faces Nasdaq Delisting Warning — 8-K · Aug 30, 2024
- Cyclacel Pharmaceuticals Faces Nasdaq Delisting Warning — 8-K · Aug 26, 2024
- Verastem to Acquire Cyclacel Pharmaceuticals for $115M — 8-K · Aug 22, 2024
- Cyclacel Pharmaceuticals Files 8-K on Financials — 8-K · Aug 14, 2024
- Cyclacel Pharmaceuticals Q2 2024 Update — 10-Q · Aug 14, 2024
- Cyclacel Pharmaceuticals Holds Annual Meeting, Elects Directors — 8-K · Jun 25, 2024
- Cyclacel Pharmaceuticals Files 8-K on Financials — 8-K · May 14, 2024
- Cyclacel Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Cyclacel Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · May 8, 2024
- Cyclacel Pharmaceuticals, Inc. Files S-1 Registration Statement — S-1 · May 6, 2024
- Cyclacel Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · May 2, 2024
- Cyclacel Pharmaceuticals Files 10-K/A Amendment — 10-K/A · Apr 29, 2024
- Cyclacel Pharmaceuticals Files 8-K Report — 8-K · Apr 26, 2024
- Cyclacel Pharmaceuticals Files Amendment to S-1 Registration Statement — S-1/A · Apr 25, 2024
- Cyclacel Pharmaceuticals Files Amendment to S-1 Registration Statement — S-1/A · Apr 19, 2024
- Cyclacel Pharmaceuticals to Delist from Nasdaq — 8-K · Mar 28, 2024
- Cyclacel Pharmaceuticals Files S-1 Registration Statement — S-1 · Mar 22, 2024
- Cyclacel Pharmaceuticals, Inc. Files 2023 Annual Report (10-K) — 10-K · Mar 21, 2024
- Cyclacel Pharmaceuticals Files 8-K Report — 8-K · Mar 19, 2024
- Cyclacel Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Cyclacel Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Cyclacel Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Cyclacel Pharmaceuticals Files S-1/A Amendment — S-1/A · Feb 8, 2024
- Acorn Bioventures Divests Cyclacel Pharma Stake — SC 13G/A · Feb 7, 2024
- Cyclacel Pharma 8-K: Officer/Director Changes, Potential New Communications — 8-K · Jan 30, 2024
- Cyclacel Pharmaceuticals Files S-1 Registration Statement — S-1 · Jan 19, 2024
- Cyclacel Confirms Nasdaq Listing for Common & Preferred Stock — 8-K · Jan 12, 2024
- Altium Capital Takes 9.99% Stake in Cyclacel Pharma — SC 13G · Jan 10, 2024
- Cyclacel Pharma 8-K: Common Stock Registered Under Exchange Act — 8-K · Jan 9, 2024
- Cyclacel Confirms Nasdaq Listing for Common Stock — 8-K · Jan 4, 2024
- Lind Global Fund II Takes 9.99% Stake in Cyclacel Pharma — SC 13G · Jan 4, 2024